Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals (Orchid Chemicals) has received an approval from the USFDA for its abbreviated new drug application (ANDA) for Olanzapine Tablets in the 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths.
Olanzapine tablets are the generic equivalent of Eli Lilly’s Zyprexa tablets. For the twelve months ending December 31, 2011 the total sales for this product in the US were about $3.3 billion.
Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).
